Literature DB >> 6769466

Sequential changes in factor VIII and platelets preceding deep vein thrombosis in patients with spinal cord injury.

E C Rossi, D Green, J S Rosen, S M Spies, J S Jao.   

Abstract

The relationships between factor VIII associated activities, platelet function, and venous thrombosis were studied in 18 patients with lower limb paralysis following acute spinal cord injury (SCI). Deep vein thrombosis (DVT) was detected in 13 patients (72%). Eight of the 13 thromboses were documented between 6 and 8 d following injury while the other five episodes were noted on days 11 (two), 13, 18 and 22. The detection of thrombosis was preceded by marked increases in VIIIR:Ag and VIII:RCoF whereas VIII:C was only marginally increased. The platelet aggregation response to collagen was hyperactive by the sixth day while the platelet aggregate ratio (PAR) did not become abnormal until after DVT was detected. These studies suggest a chronology in the series of events leading to DVT in patients with lower limb paralysis following SCI. Initial elevations in VIII:Ag and VIII:RCoF are followed in sequence by increased platelet responsiveness to collagen, the occurrence of DVT, and the appearance of circulating platelet aggregates. Conceivably, VIIIR:Ag elaborated by endothelial cells alters platelet reactivity and provides an important determinant for venous thrombosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769466     DOI: 10.1111/j.1365-2141.1980.tb03819.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Physical medicine and rehabilitation-important advances in clinical medicine: mechanical prophylaxis of deep vein thrombosis.

Authors:  J S Rosen
Journal:  West J Med       Date:  1984-04

2.  D-dimer monitoring combined with ultrasonography improves screening for asymptomatic venous thromboembolism in acute spinal cord injury.

Authors:  Gentaro Kumagai; Kanichiro Wada; Hitoshi Kudo; Toru Asari; Nana Ichikawa; Yasuyuki Ishibashi
Journal:  J Spinal Cord Med       Date:  2018-09-10       Impact factor: 1.985

3.  Factor VIII May Predict Catheter-Related Thrombosis in Critically Ill Children: A Preliminary Study.

Authors:  Edward Vincent S Faustino; Simon Li; Cicero T Silva; Matthew G Pinto; Li Qin; Joana A Tala; Henry M Rinder; Gary M Kupfer; Eugene D Shapiro
Journal:  Pediatr Crit Care Med       Date:  2015-07       Impact factor: 3.624

4.  Prevention of Venous Thromboembolism in Individuals with Spinal Cord Injury: Clinical Practice Guidelines for Health Care Providers, 3rd ed.: Consortium for Spinal Cord Medicine.

Authors: 
Journal:  Top Spinal Cord Inj Rehabil       Date:  2016

5.  Elevated von Willebrand factor antigen is an early plasma predictor of acute lung injury in nonpulmonary sepsis syndrome.

Authors:  D B Rubin; J P Wiener-Kronish; J F Murray; D R Green; J Turner; J M Luce; A B Montgomery; J D Marks; M A Matthay
Journal:  J Clin Invest       Date:  1990-08       Impact factor: 14.808

6.  Venous thromboembolism in acute spinal cord injury patients.

Authors:  Shyam K Saraf; Raj Jb Rana; Om P Sharma
Journal:  Indian J Orthop       Date:  2007-07       Impact factor: 1.251

7.  Deep vein thrombosis prophylaxis in trauma patients.

Authors:  Serdar Toker; David J Hak; Steven J Morgan
Journal:  Thrombosis       Date:  2011-05-15

Review 8.  Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator.

Authors:  Argyris Tzouvelekis; Ioannis Pneumatikos; Demosthenes Bouros
Journal:  Respir Res       Date:  2005-06-22

Review 9.  Thromboembolism in the Sub-Acute Phase of Spinal Cord Injury: A Systematic Review of the Literature.

Authors:  Samer Alabed; Maurizio Belci; Joost J Van Middendorp; Ahmed Al Halabi; Tom M Meagher
Journal:  Asian Spine J       Date:  2016-10-17

Review 10.  MRI analysis and clinical significance of lower extremity muscle cross-sectional area after spinal cord injury.

Authors:  Robert M Lester; Kori Johnson; Refka E Khalil; Rehan Khan; Ashraf S Gorgey
Journal:  Neural Regen Res       Date:  2017-05       Impact factor: 5.135

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.